Muscle ultrasound: Present state and future opportunities

Juerd Wijntjes, Nens van Alfen, Juerd Wijntjes, Nens van Alfen

Abstract

Muscle ultrasound is a valuable addition to the neuromuscular toolkit in both the clinic and research settings, with proven value and reliability. However, it is currently not fulfilling its full potential in the diagnostic care of patients with neuromuscular disease. This review highlights the possibilities and pitfalls of muscle ultrasound as a diagnostic tool and biomarker, and discusses challenges to its widespread implementation. We expect that limitations in visual image interpretation, posed by user inexperience, could be overcome with simpler scoring systems and the help of deep-learning algorithms. In addition, more information should be collected on the relation between specific neuromuscular disorders, disease stages, and expected ultrasound abnormalities, as this will enhance specificity of the technique and enable the use of muscle ultrasound as a biomarker. Quantified muscle ultrasound gives the most sensitive results but is hampered by the need for device-specific reference values. Efforts in creating dedicated muscle ultrasound systems and artificial intelligence to help with image interpretation are expected to improve usability. Finally, the standard inclusion of muscle and nerve ultrasound in neuromuscular teaching curricula and guidelines will facilitate further implementation in practice. Our hope is that this review will help in unleashing muscle ultrasound's full potential.

Keywords: biomarker; diagnostic screening; implementation; muscle ultrasound; neuromuscular ultrasound.

Conflict of interest statement

Dr. Wijntjes has no conflict of interest to disclose. Dr. van Alfen provides muscle ultrasound consultancy for Dynacure; payment goes to her employer.

© 2020 The Authors. Muscle & Nerve published by Wiley Periodicals LLC.

Figures

FIGURE 1
FIGURE 1
Properties of sound reflections (A). Transverse and longitudinal muscle ultrasound image of the gastrocnemius muscle of a healthy person (B). Ultrasound reflections in healthy (left) and diseased (right) muscle (C) and its histologic correlation (D). Figure 1D represents a microscopic image of a muscle biopsy, which is of a smaller scale than what is seen with ultrasound
FIGURE 2
FIGURE 2
Different pathological changes on muscle ultrasound in different neuromuscular disorders. Normal “starry night” appearance of a healthy biceps brachii muscle (A). Ground glass appearance of the tibialis anterior muscle in a patient with facioscapulohumeral dystrophy (FSH) (B). Attenuation of the ultrasound beam in the rectus femoris muscle of an FSHD patient (B,C). Focal areas of increased echogenicity (arrow) in the flexor carpi radialis muscle of a dermatomyositis patient (D). See‐through appearance of the deltoid muscle of a patient with suspected myositis (E). Inflammation of the pretibial skin and subcutaneous layer (arrow) of a dermatomyositis patient (F). Patchy‐appearing biceps brachii muscle with overall high echogenicity of a patient with long‐standing myositis (G). Calcifications (arrowheads) with typical posterior acoustic shadowing in the rectus femoris muscle of a dermatomyositis patient (H). Thickening of fascia (arrow) in the rectus femoris muscle of a patient with eosinophilic fasciitis (I). Affected deep finger flexor muscles (arrow) in a patient with inclusion body myositis (J). Unaffected and affected forearm muscles in a young girl with left arm peripheral nerve trauma (K). Moth‐eaten pattern (arrowheads) in the interosseous dorsalis muscle of a patient with long‐standing neurogenic disease (L)
FIGURE 3
FIGURE 3
Heckmatt grading scale from 1‐4 (rectus femoris muscle). Grade 1: Appearance of normal muscle structure and echogenicity. Grade 2: Increased muscle grayscale level with still a distinct bone echo. Grade 3: Marked increased grayscale level of the muscle with diminished bone echo. Grade 4: Very strongly increased grayscale level with a total loss of bone echo
FIGURE 4
FIGURE 4
Grayscale histograms function in ImageJ (0 = black and 255 = white) for a region of interest (ROI) in a healthy (A) and diseased muscle (B)
FIGURE 5
FIGURE 5
Devices A and B produce different grayscale images of the same region (A). Effect of the angle of insonation on echogenicity (B). Influence of age increase on grayscale levels (C). Influence of obesity (reflected by the BMI) on grayscale levels. Subcutaneous fat layer thickness is indicated by the double arrow (D). Image quality of muscle ultrasound images in the early 1980s (original ventral leg image from the paper of Heckmatt is shown, 6 with permission) compared to current image quality of muscle ultrasound (E). Heckmatt grade 4 rectus femoris muscle of a patient with facioscapulohumeral dystrophy (FSHD) with a relatively (falsely) low Z‐score due to scattering effect (F). Gastrocnemius muscle of a patient with FSHD. The left image (asterisk) shows decreased echogenicity while the MRI shows complete fatty replacement of the same muscle (asterisk). A completely fatty degenerated muscle will have very few tissue transitions left to reflect the ultrasound beam, it will result in an, again, hypoechoic image that will look the same as the subcutaneous fat layer in terms of grayscale levels. On visual inspection however, the ultrasound images clearly shows an abnormal muscle texture with loss of the typical muscle architectural features (G)

References

    1. Rahmani N, Mohseni‐Bandpei MA, Vameghi R, Salavati M, Abdollahi I. Application of ultrasonography in the assessment of skeletal muscles in children with and without neuromuscular disorders: a systematic review. Ultrasound Med Biol. 2015;41:2275‐2283.
    1. Mah JK, van Alfen N. Neuromuscular ultrasound: clinical applications and diagnostic values. Can J Neurol Sci/J Can Des Sci Neurol. 2018;45:605‐619.
    1. van Alfen N, Gijsbertse K, de Korte CL. How useful is muscle ultrasound in the diagnostic workup of neuromuscular diseases? Curr Opin Neurol. 2018;31:568‐574.
    1. Pillen S, Arts IMP, Zwarts MJ. Muscle ultrasound in neuromuscular disorders. Muscle Nerve. 2008;37:679‐693.
    1. Pillen S, van Alfen N, Zwarts MJ. Muscle ultrasound: a grown‐up technique for children with neuromuscular disorders. Muscle Nerve. 2008;38:1213‐1214.
    1. Heckmatt JZ, Leeman S, Dubowitz V. Ultrasound imaging in the diagnosis of muscle disease. J Pediatr. 1982;101:656‐660.
    1. Pillen S, van Keimpema M, Nievelstein RAJ, Verrips A, van Kruijsbergen‐Raijmann W, Zwarts MJ. Skeletal muscle ultrasonography: Visual versus quantitative evaluation. Ultrasound Med Biol. 2006;32:1315‐1321.
    1. Brockmann K, Becker P, Schreiber G, Neubert K, Brunner E, Bönnemann C. Sensitivity and specificity of qualitative muscle ultrasound in assessment of suspected neuromuscular disease in childhood. Neuromuscul Disord. 2007;17:517‐523.
    1. Pillen S, Morava E, Van Keimpema M, et al. Skeletal muscle ultrasonography in children with a dysfunction in the oxidative phosphorylation system. Neuropediatrics. 2006;37:142‐147.
    1. Adler RS, Garofalo G. Ultrasound in the evaluation of the inflammatory myopathies. Inflamm Myopathies. 2009;11:147‐164.
    1. Lacourpaille L, Gross R, Hug F, et al. Effects of Duchenne muscular dystrophy on muscle stiffness and response to electrically‐induced muscle contraction: a 12‐month follow‐up. Neuromuscul Disord. 2017;27:214‐220.
    1. Dubois GJR, Bachasson D, Lacourpaille L, Benveniste O, Hogrel JY. Local texture anisotropy as an estimate of muscle quality in ultrasound imaging. Ultrasound Med Biol. 2018;44:1133‐1140.
    1. Arts IMP, Overeem S, Pillen S, et al. Muscle ultrasonography: a diagnostic tool for amyotrophic lateral sclerosis. Clin Neurophysiol. 2012;123:1662‐1667.
    1. Misawa S, Noto Y, Shibuya K, et al. Ultrasonographic detection of fasciculations markedly increases diagnostic sensitivity of ALS. Neurology. 2011;77:1532‐1537.
    1. Swash M, De Carvalho M. Muscle ultrasound detects fasciculations and facilitates diagnosis in ALS. Neurology. 2011;77:1508‐1509.
    1. Simon NG. Dynamic muscle ultrasound ‐ another extension of the clinical examination. Clin Neurophysiol. 2015;126:1466‐1467.
    1. Grimm A, Prell T, Décard BF, et al. Muscle ultrasonography as an additional diagnostic tool for the diagnosis of amyotrophic lateral sclerosis. Clin Neurophysiol. 2015;126:820‐827.
    1. Hobson‐Webb LD, Simmons Z. Ultrasound in the diagnosis and monitoring of amyotrophic lateral sclerosis: a review. Muscle Nerve. 2019;60:114‐123.
    1. Johansson MT, Ellegaard HR, Tankisi H, Fuglsang‐Frederiksen A, Qerama E. Fasciculations in nerve and muscle disorders—A prospective study of muscle ultrasound compared to electromyography. Clin Neurophysiol. 2017;128:2250‐2257.
    1. Gijsbertse K, Bakker M, Sprengers A, et al. Computer‐aided detection of fasciculations and other movements in muscle with ultrasound: development and clinical application. Clin Neurophysiol. 2018;129:2567‐2576.
    1. Oppersma E, Hatam N, Doorduin J, et al. Functional assessment of the diaphragm by speckle tracking ultrasound during inspiratory loading. J Appl Physiol. 2017;123:1063‐1070.
    1. Finkel RS, Mercuri E, Darras BT, et al. Nusinersen versus sham control in infantile‐onset spinal muscular atrophy. N Engl J Med. 2017;377:1723‐1732.
    1. Goselink RJM, Schreuder THA, Mul K, et al. Muscle ultrasound is a responsive biomarker in facioscapulohumeral dystrophy. Neurology. 2020;94:e1488–e1494. 10.1212/WNL.0000000000009211.
    1. Jansen M, van Alfen N, van der Nijhuis SMWG, van Dijk JP, Pillen S, de IJM G. Quantitative muscle ultrasound is a promising longitudinal follow‐up tool in Duchenne muscular dystrophy. Neuromuscul Disord. 2012;22:306‐317.
    1. Shahrizaila N, Noto Y, Simon NG, et al. Quantitative muscle ultrasound as a biomarker in Charcot‐Marie‐tooth neuropathy. Clin Neurophysiol. 2017;128:227‐232.
    1. Zaidman CM, Wu JS, Kapur K, et al. Quantitative muscle ultrasound detects disease progression in Duchenne muscular dystrophy. Ann Neurol. 2017;81:633‐640.
    1. Mul K, Vincenten SCC, Voermans NC, et al. Adding quantitative muscle MRI to the FSHD clinical trial toolbox. Neurology. 2017;89:2057‐2065.
    1. Zaidman CM, Malkus EC, Siener C, Florence J, Pestronk A, Al‐Lozi M. Qualitative and quantitative skeletal muscle ultrasound in late‐onset acid maltase deficiency. Muscle Nerve. 2011;44:418‐423.
    1. Mul K, Horlings CGC, Vincenten SCC, Voermans NC, van Engelen BGM, van Alfen N. Quantitative muscle MRI and ultrasound for facioscapulohumeral muscular dystrophy: complementary imaging biomarkers. J Neurol. 2018;265:2646‐2655.
    1. Reimers CD, Finkenstaedt M. Muscle imaging in inflammatory myopathies. Curr Opin Rheumatol. 1997;9:475‐485.
    1. Bhansing KJ, Van Rosmalen MH, Van Engelen BG, Vonk MC, Van Riel PL, Pillen S. Increased fascial thickness of the deltoid muscle in dermatomyositis and polymyositis: an ultrasound study. Muscle Nerve. 2015;52:534‐539.
    1. Bhansing KJ, van Rosmalen MH, van Engelen BG, van Riel PL, Pillen S, Vonk MC. Muscle ultrasonography is a potential tool for detecting fasciitis in dermatomyositis and polymyositis: comment on the article by Yoshida et al. Arthritis Rheumatol. 2017;69:2248‐2249.
    1. Noto YI, Shiga K, Tsuji Y, et al. Contrasting echogenicity in flexor digitorum profundus‐flexor carpi ulnaris: a diagnostic ultrasound pattern in sporadic inclusion body myositis. Muscle Nerve. 2014;49:745‐748.
    1. Ebert SE, Brenzy K, Cartwright MS. Neuromuscular ultrasound as an initial evaluation for suspected myopathy: a case report. Muscle Nerve. 2019;59:E31‐E32.
    1. van Baalen A. Muscle fibre type grouping in high resolution ultrasound. Arch Dis Child. 2005;90:1189‐1189.
    1. Tsuji Y, Noto Y, Shiga K, Teramukai S, Nakagawa M, Mizuno T. A muscle ultrasound score in the diagnosis of amyotrophic lateral sclerosis. Clin Neurophysiol. 2017;128:1069‐1074.
    1. Abraham A, Drory VE, Fainmesser Y, Lovblom LE, Bril V. Quantitative sonographic evaluation of muscle thickness and fasciculation prevalence in healthy subjects. Muscle Nerve. 2020;61:234‐238.
    1. Mateos‐Angulo A, GalÁN‐Mercant A, Cuesta‐Vargas AI. Ultrasound muscle assessment and nutritional status in institutionalized older adults: a pilot study. Nutrients. 2019;11:1–9.
    1. Verhulst FV, Leeuwesteijn AEEPM, JWK L, ACH G, Van Alfen N, Pillen S. Quantitative ultrasound of lower leg and foot muscles: feasibility and reference values. Foot Ankle Surg. 2011;17:145‐149.
    1. Scholten RR, Pillen S, Verrips A, Zwarts MJ. Quantitative ultrasonography of skeletal muscles in children: Normal values. Muscle Nerve. 2003;27:693‐698.
    1. Maurits NM, Bollen AE, Windhausen A, De Jager AEJ, Van Der Hoeven JH. Muscle ultrasound analysis: Normal values and differentiation between myopathies and neuropathies. Ultrasound Med Biol. 2003;29:215‐225.
    1. Ticinesi A, Meschi T, Narici MV, Lauretani F, Maggio M. Muscle ultrasound and sarcopenia in older individuals: a clinical perspective. J Am Med Dir Assoc. 2017;18:290‐300.
    1. Nijboer‐Oosterveld J, Van Alfen N, Pillen S. New normal values for quantitative muscle ultrasound: obesity increases muscle echo intensity. Muscle Nerve. 2011;43:142‐143.
    1. Heckmatt JZ, Pier N, Dubowitz V. Real‐time ultrasound imaging of muscles. Muscle Nerve. 1988;11:56‐65.
    1. Brandsma R, Verbeek RJ, Maurits NM, et al. Visual screening of muscle ultrasound images in children. Ultrasound Med Biol. 2014;40:2345‐2351.
    1. Pillen S, Scholten RR, Zwarts MJ, Verrips A. Quantitative skeletal muscle ultrasonography in children with suspected neuromuscular disease. Muscle Nerve. 2003;27:699‐705.
    1. Pillen S, Verrips A, van Alfen N, Arts IMP, Sie LTL, Zwarts MJ. Quantitative skeletal muscle ultrasound: diagnostic value in childhood neuromuscular disease. Neuromuscul Disord. 2007;17:509‐516.
    1. Zaidman CM, Holland MR, Anderson CC, Pestronk A. Calibrated quantitative ultrasound imaging of skeletal muscle using backscatter analysis. Muscle Nerve. 2008;38:893‐898.
    1. Zaidman CM, Holland MR, Hughes MS. Quantitative ultrasound of skeletal muscle: reliable measurements of calibrated muscle backscatter from different ultrasound systems. Ultrasound Med Biol. 2012;38:1618‐1625.
    1. Knipp BS, Zagzebski JA, Wilson TA, Dong F, Madsen EL. Attenuation and backscatter estimation using video signal analysis applied to B‐mode images. Ultrason Imaging. 1997;19:221‐233.
    1. Molinari F, Caresio C, Acharya UR, Mookiah MRK, Minetto MA. Advances in quantitative muscle ultrasonography using texture analysis of ultrasound images. Ultrasound Med Biol. 2015;41:2520‐2532.
    1. Haralick, RM , Shanmugam KA, Dinstein I. Textural features. IEEE Trans Syst Man Cybern 1973; SMC‐3, No.:610–621.
    1. Sogawa K, Nodera H, Takamatsu N, et al. MUSCULOSKELETAL IMAGING: texture analysis of muscle US data to differentiate neurogenic and myogenic disease Sogawa et al. Radiology. 2017;283:492‐498.
    1. Martínez‐Payá JJ, Ríos‐Díaz J, Del Baño‐Aledo ME, Tembl‐Ferrairó JI, Vazquez‐Costa JF, Medina‐Mirapeix F. Quantitative muscle ultrasonography using textural analysis in amyotrophic lateral sclerosis. Ultrason Imaging. 2017;39:357‐368.
    1. Gijsbertse K, Goselink R, Lassche S, et al. Ultrasound imaging of muscle contraction of the Tibialis anterior in patients with Facioscapulohumeral dystrophy. Ultrasound Med Biol. 2017;43:2537‐2545.
    1. Regensburger M, Tenner F, Möbius C, Schramm A. Detection radius of EMG for fasciculations: empiric study combining ultrasonography and electromyography. Clin Neurophysiol. 2018;129:487‐493.
    1. Reimers CD, Ziemann U, Scheel A, Rieckmann P, Kunkel M, Kurth C. Fasciculations: clinical, electromyographic, and ultrasonographic assessment. J Neurol. 1996;243:579‐584.
    1. Tsugawa J, Dharmadasa T, Ma Y, Huynh W, Vucic S, Kiernan MC. Fasciculation intensity and disease progression in amyotrophic lateral sclerosis. Clin Neurophysiol. 2018;129:2149‐2154.
    1. Noto YI, Shibuya K, Shahrizaila N, et al. Detection of fasciculations in amyotrophic lateral sclerosis: the optimal ultrasound scan time. Muscle Nerve. 2017;56:1068‐1071.
    1. Bokuda K, Shimizu T, Kimura H, et al. Relationship between EMG‐detected and ultrasound‐detected fasciculations in amyotrophic lateral sclerosis: a prospective cohort study. Clin Neurophysiol. 2020;131:259–264.
    1. Regensburger M. Which kinds of fasciculations are missed by ultrasonography in ALS? Clin Neurophysiol. 2019;131:237‐238.
    1. Van Alfen N, Nienhuis M, Zwarts MJ, Pillen S. Detection of fibrillations using muscle ultrasound: diagnostic accuracy and identification of pitfalls. Muscle Nerve. 2011;43:178‐182.
    1. Pillen S, Nienhuis M, van Dijk JP, Arts IMP, van Alfen N, Zwarts MJ. Muscles alive: ultrasound detects fibrillations. Clin Neurophysiol. 2009;120:932‐936.
    1. Dengler R. Dynamic muscle ultrasound conquers another domain of needle EMG, the detection of fibrillations. Clin Neurophysiol. 2009;120:843‐844.
    1. Pillen S, Van Dijk JP, Weijers G, Raijmann W, De Korte CL, Zwarts MJ. Quantitative gray‐scale analysis in skeletal muscle ultrasound: a comparison study of two ultrasound devices. Muscle Nerve. 2009;39:781‐786.
    1. O'brien TG, Cazares Gonzalez ML, Ghosh PS, Mandrekar J, Boon AJ. Reliability of a novel ultrasound system for gray‐scale analysis of muscle. Muscle Nerve. 2017;56:408‐412.
    1. Li X, Zhang S, Zhang Q, et al. Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study. Lancet Oncol. 2019;20:193‐201.
    1. Burlina P, Billings S, Joshi N, Albayda J. Automated diagnosis of myositis from muscle ultrasound: exploring the use of machine learning and deep learning methods. PLoS One. 2017;12:1‐15.
    1. Burlina P, Joshi N, Billings S, Wang IJ, Albayda J. Deep embeddings for novelty detection in myopathy. Comput Biol Med. 2019;105:46‐53.
    1. Zaidman CM, Van Alfen N. Ultrasound in the assessment of Myopathic disorders. J Clin Neurophysiol. 2016;33:103‐111.
    1. Boone WJ. Rasch analysis for instrument development: Why,when,and how? CBE Life Sci Educ. 2016;15:1–7.
    1. Tawfik EA, Cartwright MS, Grimm A, et al. Guidelines for neuromuscular ultrasound training. Muscle Nerve. 2019;60:361‐366.
    1. Walker FO, Alter KE, Boon AJ, et al. Qualifications for practitioners of neuromuscular ultrasound: position statement of the American Association of Neuromuscular and Electrodiagnostic Medicine. Muscle Nerve. 2010;42:442‐444.
    1. Hobson‐Webb LD, Cartwright MS. Advancing neuromuscular ultrasound through research: finding common sound. Muscle Nerve. 2017;56:375‐378.
    1. French C, Cartwright MS, Hobson‐Webb LD, et al. Evidence‐based guideline: neuromuscular ultrasound for the diagnosis of carpal tunnel syndrome. Muscle Nerve. 2012;46:287‐293.
    1. de Carvalho M. Ultrasound in ALS: is it a sound method? Clin Neurophysiol. 2015;126:651‐652.
    1. Ng KW, Connolly AM, Zaidman CM. Quantitative muscle ultrasound measures rapid declines over time in children with SMA type 1. J Neurol Sci. 2015;358:178‐182.
    1. Zaidman CM, Malkus EC, Connolly AM. Muscle ultrasound quantifies disease progression over time in infants and young boys with duchenne muscular dystrophy. Muscle Nerve. 2015;52:334‐338.
    1. Dietz AR, Connolly A, Dori A, Zaidman CM. Intramuscular blood flow in Duchenne and Becker muscular dystrophy: quantitative power Doppler sonography relates to disease severity. Clin Neurophysiol. 2020;131:1‐5.

Source: PubMed

Подписаться